NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations is a research paper published in Cancer Discovery (2024). On theSindex it has a DataRank of 0.587. It has been cited 49 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.587
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA164273
Fundação para a Ciência e a Tecnologia, I.P.
Grant: Incentivo/SAU/LA0002/2013
Incentive - LA 2 - 2013
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 2R01CA164273-11A1
Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
FWCI
13.83
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals